Evidence map›Paper›PMID 29339270›Full record

ReviewBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2018

Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium (HAPLO2016), San Diego, California, December 1, 2016.

Monzr M Al Malki, Richard Jones, Qing Ma, Dean Lee, Yair Reisner, Jeffrey S Miller, Peter Lang, Suradej Hongeng, Parameswaran Hari, Samuel Strober and 8 more

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Haploidentical HSCT in the Treatment of Pediatric Hematological Disorders.International journal of molecular sciences · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 13 institutions in 6 countries.

Monzr M Al MalkiDepartment of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
Richard JonesDivision of Hematologic Malignancies, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, Baltimore, Maryland.
Qing MaThe University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Dean LeeThe University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Yair ReisnerDepartment of Immunology, Weizmann Institute, Rehovot, Israel.
Jeffrey S MillerBlood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota.
Peter LangDepartment of General Paediatrics, Oncology/Haematology, Tübingen University Hospital for Children and Adolescents, Tübingen, Germany.
Suradej HongengDepartment of Pediatrics, Mahidol University, Bangkok, Thailand.
Parameswaran HariDivision of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Samuel StroberDivision of Immunology and Rheumatology, Department of Medicine, Stanford Medical School, Palo Alto, California.
Jianhua YuDivision of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio.
Richard MaziarzCenter for Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
Domenico MavilioUnit of Clinical and Experimental Immunology, Humanitas Clinical and Research Center, Milan, Italy; Department of Medical Biotechnologies and Translational Medicine (BioMeTra), University of Milan, Milan, Italy.
Denis-Claude RoyBlood and Marrow Transplantation Program, Hôpital Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, Quebec, Canada.
Chiara BoniniExperimental Hematology Unit, San Raffaele Hospital, Milan, Italy.
Richard E ChamplinThe University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Ephraim J FuchsDivision of Hematologic Malignancies, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, Baltimore, Maryland.
Stefan O CiureaThe University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address: sciurea@mdanderson.org.
The University of Texas MD Anderson Cancer Center · USJohns Hopkins University · USCity Of Hope National Medical Center · USHôpital Maisonneuve-Rosemont · CAHumanitas University · ITMahidol University · THMedical College of Wisconsin · USOregon Health & Science University · USStanford Medicine · USThe Ohio State University · USUniversity Children's Hospital Tübingen · DEUniversity of Minnesota · USWeizmann Institute of Science · IL

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

The resurgence of haploidentical stem cell transplantation (HaploSCT) over the last decade is one of the most important advances in the field of hematopoietic stem cell transplantation (HSCT). The modified platforms of T cell depletion either ex vivo (CD34

Indexed as

Congresses as TopicCaliforniaCell- and Tissue-Based TherapyHemoglobinopathiesHumansImmunotherapyLeukocyte Reduction ProceduresNeoplasmsOrgan TransplantationStem Cell TransplantationTransplantation, HaploidenticalCellular therapyHaploidentical transplantationImmunologic reconstitutionPost-transplantation cyclophosphamideT cell depletion

Identifiers

PMID29339270
PMCPMC7187910
OpenAlexW2783186118

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.